In short
This article summarizes key findings from clinical trials investigating the use of follitropin alfa, a recombinant human follicle-stimulating hormone (FSH), in assisted reproductive technology procedures like in vitro fertilization (IVF). The trials examined the efficacy and safety of follitropin alfa compared to other gonadotropins for ovarian stimulation in women undergoing fertility treatments. Key outcomes assessed include number of oocytes retrieved, pregnancy rates, and safety profiles.
At a glance
- Drug
- Follitropin alfa (recombinant human FSH)
- Indication
- Ovarian stimulation for assisted reproductive technologies
- Administration
- Subcutaneous injection, typically 150-300 IU daily for up to 16 days
- Efficacy
- Comparable to other gonadotropins in number of oocytes retrieved and pregnancy rates
- Safety
- Generally well-tolerated; main risks include OHSS and multiple pregnancies
- Monitoring
- Ultrasound and blood tests to assess ovarian response and adjust dosing
- Comparators
- Gonal-F, corifollitropin alfa, urinary gonadotropins
What is Follitropin Alfa?
Follitropin alfa is a medication used in fertility treatments. It is a type of hormone known as a recombinant human follicle-stimulating hormone (r-hFSH). This means it is a laboratory-made version of the natural hormone that stimulates egg production in women. Follitropin alfa is known by several brand names, including Gonal-F, Puregon, Primapur, and Gonapure.
How Does It Work?
Follitropin alfa works by stimulating the ovaries to produce more than one egg at a time. In a natural menstrual cycle, usually only one egg matures and is released. However, for certain fertility treatments, it's beneficial to have multiple mature eggs available. The medication mimics the action of the body's natural follicle-stimulating hormone, encouraging the growth and development of ovarian follicles, which contain the eggs.
Conditions Treated
Follitropin alfa is primarily used to treat infertility in women. It is prescribed for various conditions and procedures, including:
- Assisted Reproductive Technologies (ART): This includes treatments like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).
- Ovulation Induction: For women who do not ovulate regularly or at all.
- Controlled Ovarian Stimulation: To produce multiple eggs for fertility treatments.
- Female Infertility: Various causes of infertility in women.
Administration
Follitropin alfa is typically administered as a subcutaneous injection, meaning it is injected just under the skin. The medication often comes in pre-filled pens or syringes for easy self-administration at home. The dosage and duration of treatment can vary depending on the individual patient and the specific fertility treatment plan. Generally, the starting dose is between 75-150 IU (International Units) per day, and treatment may last for 7-16 days.
Effectiveness
The effectiveness of follitropin alfa is typically measured by several factors:
- Number of oocytes retrieved: This refers to the number of eggs collected after stimulation. A higher number of eggs generally increases the chances of successful fertilization and pregnancy.
- Quality of oocytes: The medication aims to produce mature, high-quality eggs suitable for fertilization.
- Pregnancy rates: This includes biochemical pregnancies (early positive pregnancy test) and clinical pregnancies (confirmed by ultrasound).
- Live birth rates: The ultimate measure of success in fertility treatments.
Studies have shown that follitropin alfa is effective in stimulating ovarian follicle development and increasing the number of mature eggs available for fertility treatments.
Side Effects
Like all medications, follitropin alfa can cause side effects. Common side effects may include:
- Injection site reactions (redness, pain, itching, swelling, bruising)
- Headache
- Abdominal pain or bloating
- Nausea
- Ovarian Hyperstimulation Syndrome (OHSS): A condition where the ovaries become swollen and painful. This is a serious but rare side effect that requires immediate medical attention.
It's important to discuss potential side effects with your healthcare provider before starting treatment.
Comparison with Other Treatments
Follitropin alfa is one of several gonadotropins used in fertility treatments. Other similar medications include:
- Corifollitropin alfa (Elonva): This is a long-acting FSH that requires less frequent injections.
- Follitropin beta (Puregon): Another type of recombinant FSH.
- Follitropin delta (Rekovelle): A newer recombinant FSH that is dosed based on the patient's weight and AMH levels.
Studies have been conducted to compare the efficacy and safety of these different treatments. Generally, they have been found to have similar effectiveness, with some differences in dosing schedules and individualization of treatment.
Ongoing Research
Research on follitropin alfa and other fertility treatments is ongoing. Current areas of study include:
- Comparing different dosing protocols to optimize treatment outcomes.
- Investigating the effects of different stimulation protocols on embryo development.
- Studying the efficacy and safety of biosimilar versions of follitropin alfa.
- Exploring combination treatments with other medications to improve outcomes.
These ongoing studies aim to further improve the effectiveness and safety of fertility treatments using follitropin alfa and related medications.